Endogastric Solutions
About EndoGastric Solutions: Based in Redmond, WA, EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF¬) procedure„a barely invasive solution that addresses a significant unmet clinical need. About Transoral Incisionless Fundoplication (TIF¬) procedure for reflux: Performed without the need for external incisions through the skin, the TIF procedure offers patients who require an anatomical repair another treatment option to correct the underlying cause of GERD. Studies show that for up to three years after the TIF procedure esophageal inflammation (esophagitis) is eliminated and most patients are able to stop using daily PPI medications to control symptoms. To locate a physician visit GERDHelp.com. About EsophyX¬ technology: The original EsophyX device was cleared by the FDA in 2007. EGS launched the third generation EsophyX device, the EsophyX Z in 2015. The technology has continued to evolve and is a clinically-backed tool for physician use in the treatment of GERD. The EsophyX technology now enables surgeons and gastroenterologists to use a wider selection of endoscopes_including low profile and larger high-definition models„to treat the underlying anatomical cause of GERD. The EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids from washing back up into the esophagus. The device is inserted through the patientÍs mouth with direct visual guidance from an endoscope.
Medical Devices
50 - 200
Redmond, WA, United States
About

About EndoGastric Solutions:
Based in Redmond, WA, EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF¬) procedure„a barely invasive solution that addresses a significant unmet clinical need.

About Transoral Incisionless Fundoplication (TIF¬) procedure for reflux:
Performed without the need for external incisions through the skin, the TIF procedure offers patients who require an anatomical repair another treatment option to correct the underlying cause of GERD. Studies show that for up to three years after the TIF procedure esophageal inflammation (esophagitis) is eliminated and most patients are able to stop using daily PPI medications to control symptoms.

To locate a physician visit GERDHelp.com.

About EsophyX¬ technology:
The original EsophyX device was cleared by the FDA in 2007. EGS launched the third generation EsophyX device, the EsophyX Z in 2015. The technology has continued to evolve and is a clinically-backed tool for physician use in the treatment of GERD. The EsophyX technology now enables surgeons and gastroenterologists to use a wider selection of endoscopes_including low profile and larger high-definition models„to treat the underlying anatomical cause of GERD. The EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids from washing back up into the esophagus. The device is inserted through the patientÍs mouth with direct visual guidance from an endoscope.

Site Traffic
  • 4970224 Global Rank
  • 1052547
    United States
Traffic Sources
  • Search
    92.83%
  • Direct
    7.17%
  • Display
    0.00%
  • Mail
    0.00%
  • Referrals
    0.00%
  • Social
    0.00%
Powered by
Alexa Traffic Data
Global Rank 1,000,381
2,951,115
Bangladesh Rank 11,629
10
Bangladesh Page Views 100.0%
0.5%
Top Countries
Top Search Keywords
  • Bike Shops
Ad Intelligence
  • Standard
    100.00%
Ads Seen Recently
2
Latest Publishers
Longest Running Ad
Endogastric Solutions
Device
Desktop
Dimensions
728x90
Endogastric Solutions
Device
Desktop
Dimensions
300x250
Endogastric Solutions
Device
Desktop
Dimensions
728x90
Endogastric Solutions receives up to 0.07M pageviews per day, in countries such as United States.

They are headquartered at Redmond, WA, United States, and have 3 advertising & marketing contacts listed on Kochava. Endogastric Solutions works with Advertising technology companies such as Dstillery, Bizo, LinkedIn Ads, AppNexus, AppNexus Segment Pixel, DoubleClick.Net, Twitter Ads, Outbrain, Outbrain Pixel.